medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2016, Number 05

<< Back Next >>

Ginecol Obstet Mex 2016; 84 (05)

Evaluation of visceral adipose tissue and lipid level in premenopausal and postmenopausal women´s

Díaz-Martínez AG, Basurto-Acevedo L, Vega-García S, Saucedo-García R, Hernández-Valencia M, Zárate- Treviño A, González-Escudero EA, Córdova-Pérez N, Sánchez-Huerta LA, García-Latorre E

Language: Spanish
References: 33
Page: 294-300
PDF size: 491.00 Kb.


ABSTRACT

Background: Postmenopausal women present weight gain and intensification of obesity, especially visceral adipose tissue (VAT) increases in postmenopausal women. But it is still not clear whether abdominal fat increases during this stage independently of body weight.
Objetive: compare the VAT and lipid profile between postmenopausal and premenopausal Mexican women.
Methods: A case control study in postmenopausal women matched for BMI with premenopausal women. Anthropometric and laboratory measurements as well as body composition analysis were performed.
Results: VAT was increased in postmenopausal women in contrast with premenopausal women (114.8 ± 39.5 vs 97.3 ± 29.0, p‹0.05). Compared with premenopausal women, postmenopausal women showed higher total cholesterol (231.6 ± 56.1 vs 206.8 ± 29.5 p ‹0.05), and LDL-cholesterol levels (145.9 ± 48.3 vs 121.7 ± 34.1, p ‹ 0.05), whereas HDL-cholesterol remained unchanged.
Conclusion: The results of the present study have demonstrated that Mexican postmenopausal women had a significant increment in visceral adipose tissue and in other metabolic risk factors, independent of the body mass index.


REFERENCES

  1. Mattsson C, Olsson T. Estrogens and glucocorticoid hormones in adipose tissue metabolism. Curr Med Chem 2007;14: 2918-1924.

  2. Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring) 2012;21:439-47.

  3. Arriero PJ, Goran MI, Poehlman ET. Resting metabolic rate is lower in females compared to males. J Appl Physiol 1993;75: 2514-2520.

  4. Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 2013;62:921-5.

  5. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando- Hernández S, Franco A, Cuevas-Nasu L, et al. Encuesta nacional de salud y nutrición 2012. Resultados nacionales. Cuernavaca, México; Instituto Nacional de Salud Pública México, 2012.

  6. Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab 2010;95:5419-26.

  7. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, et al. Body fat distribution and risk of noninsulin- dependent diabetes mellitus in women. The Nurses’ Health Study. Am J Epidemiol 1997; 145:614-9.

  8. Després JP, Allard C, Tremblay A, Talbot J, Bouchard C. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism 1985; 34:967-73.

  9. Preis SR, Massaro JM., Robins SJ, Hoffmann U, Ramachandran SV, Irlbeck T, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham Heart Study. Obesity 2010; 18: 2191-8.

  10. Wise BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004;15:2792-800.

  11. Fernández-Muñoz MJ, Basurto-Acevedo L, Córdova-Pérez N, Vázquez-Martínez AL, Tepach-Gutiérrez N, et al. Epicar dial adipose tissue is associated with visceral fat, metabolic syndrome, and insulin resistance in menopausal women. Rev Esp Cardiol 2014;67:436-441.

  12. Cordova-Pérez N, Basurto-Acevedo L, Degollado-Córdova JA, Saucedo-García RP, Martínez-Murillo C, Zárate A, et al. Menopausal Women Have Hypofibrinolysis Even in Subclinical Stage of Atherosclerosis. Rev Invest Clin 2015;67:122-9.

  13. Morato HL, Lerman GI. Dislipidemias en el climaterio femenino y en ancianos. En: C. Posadas R. Dislipidemias y aterosclerosis. México: Editorial Interamericana, 1995;159-170.

  14. Dahlberg E. Characterization of the cytosolic estrogen receptor in rat skeletal muscle. Biochim Biophys Acta 1982;717:65-75.

  15. Poehlman ET, Toth MJ, Ades PA, Rosen CJ. Menopause associated changes in plasma lipids, insulin-like growth factor-1 and blood pressure: a longitudinal study. Eur J Clin Invest 1997;27:322-6.

  16. Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Biol 2008;108:272-80.

  17. Kirchengast S, Huber J. Body composition characteristics and fat distribution patterns in young infertile women. Fertil Steril 2004;81:539-44.

  18. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process Diabetes 2002;51:2951-8.

  19. Lonnqvist F, Thorne A, Large V, Arner P. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol 1997;17:1472-80.

  20. Hsu IR, Kim SP, Kabir M, Bergman RN. Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr 2007;86:s867-71.

  21. Tanaka Y, Kikuchi T, Nagasaki K, Hiura M, Ogawa Y, et al. Lower birth weight and visceral fat accumulation are related to hyperinsulinemia and insulin resistance in obese Japanese children. Hypertens Res 2005; 28: 529-36.

  22. Kissebah AH, Alfarsi S, Adams PW, Wynn V. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 1976;12: 563-71.

  23. Cassano PA, Segal MR, Vokonas PS, Weiss ST. Body fat distribution, blood pressure and hypertension. A prospective cohort study of men in the normative aging study. Ann Epidemiol 1990;1:33-48.

  24. Maiorana A, Del Bianco C, Cianfarani S. Adipose tissue: A metabolic regulator. potential implications for the metabolic outcome of subjects born small for gestational age (SGA). Rev Diabet Stud 2007;4:134-6.

  25. Day DS, Gozansky WS, Val Pelt Re, Schwartz R, Kohrt WM. Sex hormone suppression reduces resting energy expenditure and beta-adrenergic support of resting energy expenditure. J Clin Endocrinol Metab 2005; 90:3312-17.

  26. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10-18.

  27. Polotsky HN, Polotsky AJ. Metabolic implications of menopause. Semin Reprod Med 2010;28:426-34.

  28. Revilla R, Revilla M, Villa LF, Cortes J, Arribas I, Rico H. Changes in body composition in women treated with gonadotropin-releasing hormone agonists. Maturitas 1998;31:63-68.

  29. Day DS, Gozansky WS, Val Pelt RE, Schwartz RS, Kohrt WM. Sex hormone suppression reduces resting energy expenditure and beta-adrenergic support of resting energy expenditure. J Clin Endocrinol Metab 2005;90:3312-3317.

  30. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995;123:673-5.

  31. Nagai M, Komiya H, Mori Y, Ohta T, Kasahara Y, Ikeda Y. Estimating visceral fat area by multifrequency biolectrical impedance. Diabetes Care 2010;33:1077-9.

  32. Scheuer SJ, Faerch K, Phllipsen A, Jorgensen ME, Johansen NB, Carstensen B. Abdominal fat distribution and cardiovascular risk in men and women with different levels of glucose tolerance. J Clin Endocrinol Metab 2015;100:3340-7.

  33. Nicklas BJ, Penninx BW, Cesari M, Kritchevsky SB, Newman AB, Kanaya AM, et al. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study. Am J Epidemiol. 2004;160:741-9-




2020     |     www.medigraphic.com